Innovus Pharma appoints Robert Hoffman as VP, CFO
Mr. Hoffman is biopharmaceutical veteran with decades of experience. He will also oversee finance, accounting, human resources, information technology, and investor relations at Innovus.
Most recently, Mr. Hoffman was Chief Financial Officer of AnaptysBio, Inc., a clinical stage biopharmaceutical company.
He was part of the founding management team of Arena Pharmaceuticals in 1997, serving as Senior Vice President, Finance and Chief Financial Officer until 2015.
He also served as Chief Financial Officer for Polaris Group, a biopharmaceutical drug company, from March 2011 to August 2011.
Mr. Hoffman is a member of the board of directors of CombiMatrix Corporation, Kura Oncology, and MabVax Therapeutics Holdings.
He also was a member of the Financial Accounting Standards Board’s Small Business Advisory Committee until 2015 and is a member of the steering committee of the Association of Bioscience Financial Officers.
Mr. Hoffman received his B.B.A. from St. Bonaventure University, and is licensed as a C.P.A. (inactive) in the State of California. ■
LATEST MOVES FROM California
- HP chairman Meg Whitman steps down
- Seagate Technology promotes Dave Mosley to CEO
- Autodesk appoints Reid French to board
- Plumas Bancorp appoints Richard F. Kenny to board
- PennyMac Financial Services appoints Theodore W. Tozer to board
More inside POST
Netflix Q2 revenue $2.785 billion Earnings